This inventor holds 1 USPTO granted patent. Top assignee: Leiden University Medical Centre. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Richard De Wijn: Innovator in Melanoma Treatment
Introduction
Richard De Wijn is a notable inventor based in Nijmegen, Netherlands. He has made significant contributions to the field of medicine, particularly in the treatment of melanoma. His innovative approach has the potential to improve patient outcomes and advance medical research.
Latest Patents
Richard De Wijn holds a patent titled "Method for Predicting the Response of Melanoma Patients to a Medicament." This patent represents a crucial step in personalized medicine, allowing for tailored treatment plans based on individual patient responses.
Career Highlights
Richard is affiliated with the Leiden University Medical Centre, where he conducts research and develops innovative solutions for melanoma treatment. His work is characterized by a commitment to improving patient care through scientific advancements.
Collaborations
Richard has collaborated with esteemed colleagues, including Robby Ruijtenbeek and Sjoerd H Van Der Burg. These partnerships enhance the research efforts and contribute to the development of effective treatment strategies.
Conclusion
Richard De Wijn's contributions to melanoma treatment through his patent and collaborative efforts highlight his role as an important figure in medical innovation. His work continues to pave the way for advancements in personalized medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile